1 / 31

Dizziness

Dizziness. Pete Kang NYU School of Medicine Class of 2001. Dizziness: epidemiology. 1.5% of all hospital admissions 26% of all ED pts stated that they had experienced “dizziness” Most common non-pain-related complaint in the ED Account for 8 million outpatient visits per year in the U.S.

sherrera
Download Presentation

Dizziness

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Dizziness Pete Kang NYU School of Medicine Class of 2001

  2. Dizziness: epidemiology • 1.5% of all hospital admissions • 26% of all ED pts stated that they had experienced “dizziness” • Most common non-pain-related complaint in the ED • Account for 8 million outpatient visits per year in the U.S. • Adult > Pediatric

  3. Dizziness: differential diagnosisbroad categories of diseases • Vertigo • Near-faint or Presyncope dizziness • Psychophysiologic dizziness • Hypoglycemic dizziness • Disequilibrium • Drug-induced dizziness

  4. Vertigo: subclasses • Acute spontaneous attack • Recurrent spontaneous attacks • Recurrent episodes of positional vertigo

  5. Acute spontaneous attack of vertigo • Unilateral loss of vestibular function • Clinical presentation: • Intense sense of rotation aggravated by head motion • World turns slowly toward intact side, then quickly toward affected side • Prefers to sit upright w/ head still or to lie w/ intact side undermost • Difficulty in standing/walking; may fall toward affected side • May have nausea/vomiting, malaise, pallor, diarrhea

  6. Peripheral Severe nausea/vomiting Mild imbalance Hearing loss common Mild oscillopsia No focal signs Rapid compensation Central Mod. nausea/vomiting Severe imbalance Hearing loss rare Severe oscillopsia Focal signs Slow compensation Peripheral vs. Central lesions

  7. Viral neurolabyrinthitis • Most common; >90% of cases in younger age group w/o major vascular risk factors • Subacute onset; URI ~2 weeks prior • Unilateral caloric paresis, +/- hearing loss • No other focal signs • Symptomatic management, vestibular rehabilitation

  8. Bacterial otomastoiditis w/ labyrinth involvement • Prior infection; bony erosion seen in CT • Possible cholesteatoma • Possible complication of bacterial meningitis • Antibiotics • Surgical debridement

  9. Cerebellar infarct/hemorrhage • Elderly, w/ vascular risk factors • Other focal neurological signs present usually

  10. Multiple sclerosis • Vertigo is the presenting symptom in 5% of patients w/ MS • Multifocal neurologic symptoms/signs • Characteristic T2-intense lesions in white matter on MRI

  11. Recurrent, spontaneous attacks of vertigo • Sudden, temporary, and large reversible impairment of resting neural activity in one labyrinth or its central connections • Lasts from minutes to hours • Restoration of normal neural activity, rather than compensation

  12. Meniere’s disease • Characteristic fluctuating low-frequency hearing loss • Episodic vertigo • Roaring tinnitus • Ear pressure

  13. Autoimmune inner ear disease • May mimic Meniere’s disease • Signs/symptoms of systemic involvement • Elevated ESR, positive ANA’s/rheumatoid factor • Immunosuppression

  14. Syphilitic labyrinthitis • Similar to Meniere’s disease in signs/symptoms • Positive VDRL and/or FTA-ABS • Penicillin, steroids

  15. Migraine • Vertigo occurs in approximately 25% of migraine patients • Hearing loss infrequent • Headaches that meet International Headache Society criteria for migraine • Treat migraine

  16. Vertebrobasilar TIA • Common cause in older patients w/ risk factors • Subclavian steal syndrome • Abrupt, last several minutes • Other sx’s of posterior circulation • Antiplatelet drugs, anticoagulation

  17. Recurrent, positional vertigo • Transient excitation within the vestibular pathways triggered by change in position • Central vs. Peripheral lesions

  18. Peripheral Torsional/horizontal Latency Brief Fatigability Debris moving in semicircular canal Central Pure vertical No latency Persistent No fatigability Damage to central vestibulo-ocular pathways Brainstem or cerebellum Recurrent, positional vertigo: peripheral vs. central

  19. Benign positional vertigo (BPV) Dix-Hallpike test • 2-10 sec latency • Torsional/horizontal nystagmus • Lasts < 30 sec (fatigability) • Any deviation from this must raise suspicion for a central lesion

  20. Recurrent, positional vertigo: central lesions • Multiple sclerosis • Cerebellar tumors • Medulloblastomas • Cerebellar atrophy • Chiari type I malformation

  21. Near-faint dizziness or presyncope • “Light-headedness” before losing consciousness or fainting • Reduced blood flow to the entire brain • Causes • Vasovagal • Orthostatic hypotension • Volume depletion • Cardiac arrhythmias, cardiomyopathy, constrictive pericarditis, aortic stenosis

  22. Psychophysiologic dizziness • Associated with panic disorder (lifetime prevalence of 1.6%) • Hyperventilation  reduce pCO2  cerebral vasoconstriction  decreased cerebral blood flow • Onset with specific situations (such as public places, driving in highways, etc.)

  23. Hypoglycemic dizziness • Complication of insulin/sulfonylurea treatment • Insulinoma • Fasting • Postprandial phenomenon (functional hypoglycemia)

  24. Disequilibrium • Sensation of losing one’s balance without feeling of illusionary movement or impending LOC • Unsteadiness standing, walking • Disruption in integration between sensory inputs and motor outputs • Associated with aging

  25. Drug-induced dizziness • Aminoglycosides, cisplatin • Vertigo, disequilibrium • Damage to vestibular hair cells • Antiepileptic • Carbamazepine, pheytoin, primidone • Disequilibrium, intoxication • Tranquilizers • Barbiturates, benzodiazepines, tricyclics • Intoxication

  26. Drug-induced dizziness • Antihypertensives/diuretics • presyncope • Alcohol • Intoxication  CNS depression • Disequilibrium  cerebellar toxicity • Positional vertigo  change in cupula specific gravity

  27. Treatment: medical • Best therapy: treating the underlying disease • Indication for symptomatic therapy: • Illness is not readily treatable • Treatment must be continued for a long period before improvement • Severe and prolonged vertigo

  28. Treatment: medical • Acute severe vertigo • Promethazine (antihistamine): sedative (++), antiemetic (++) • Diazepam: sedative (+++), antiemetic (+) • Nausea & vomiting • Prochlorperazine (phenothiazine) • Metoclopramide (benzamide) • Chronic recurrent vertigo • Meclizine (antihistamine) • Dimenhydrinate (antihistamine)

  29. Treatment: surgical • Conservative surgery • Shunt surgery (decompress endolymphatic sac) • Effective in ~75% of cases • Selective section of vestibular division of CN VIII • Effective in >90% of cases • <10% significant hearing loss • Abnormal vascular loop at the brainstem insertion of CN VIII

  30. Treatment: surgical • Destructive surgery • Labyrinthectomy • Complete destruction of the end organ • Extremely high cure rate • Cost: destruction of all hearing in the involved ear

  31. Vestibular rehabilitation • Process of compensation • Requires: • Intact vision & depth perception • Normal proprioception • Intact sensation in lower limbs • Graded increase in demand for central compensation of vestibular input

More Related